ot-i peptide Search Results


90
Amgen ot-i tcr-tg mice specific for chicken ova peptide 357–364 (ot-ip) in the context of h-2kb
Ot I Tcr Tg Mice Specific For Chicken Ova Peptide 357–364 (Ot Ip) In The Context Of H 2kb, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ot-i tcr-tg mice specific for chicken ova peptide 357–364 (ot-ip) in the context of h-2kb/product/Amgen
Average 90 stars, based on 1 article reviews
ot-i tcr-tg mice specific for chicken ova peptide 357–364 (ot-ip) in the context of h-2kb - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Taconic Biosciences tcr transgenic ot-i/rag –/– mice specific for ovalbumin ( 257−264 ) (ova 257–264)
Tcr Transgenic Ot I/Rag –/– Mice Specific For Ovalbumin ( 257−264 ) (Ova 257–264), supplied by Taconic Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tcr transgenic ot-i/rag –/– mice specific for ovalbumin ( 257−264 ) (ova 257–264)/product/Taconic Biosciences
Average 90 stars, based on 1 article reviews
tcr transgenic ot-i/rag –/– mice specific for ovalbumin ( 257−264 ) (ova 257–264) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Auspep Pty peptide for the ot-i tcr, siinfekl (n4)
Peptide For The Ot I Tcr, Siinfekl (N4), supplied by Auspep Pty, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptide for the ot-i tcr, siinfekl (n4)/product/Auspep Pty
Average 90 stars, based on 1 article reviews
peptide for the ot-i tcr, siinfekl (n4) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
CH Instruments oti peptide
Oti Peptide, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oti peptide/product/CH Instruments
Average 90 stars, based on 1 article reviews
oti peptide - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
GenScript corporation ot-i plus ot-ii peptides
Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with <t>PBS</t> (Control), with both OT-I and OT-II <t>specific</t> <t>peptides</t> plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.
Ot I Plus Ot Ii Peptides, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ot-i plus ot-ii peptides/product/GenScript corporation
Average 90 stars, based on 1 article reviews
ot-i plus ot-ii peptides - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Genemed Synthesis peptides h2-k b –restricted ot-i (siinfekl)
Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with <t>PBS</t> (Control), with both OT-I and OT-II <t>specific</t> <t>peptides</t> plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.
Peptides H2 K B –Restricted Ot I (Siinfekl), supplied by Genemed Synthesis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peptides h2-k b –restricted ot-i (siinfekl)/product/Genemed Synthesis
Average 90 stars, based on 1 article reviews
peptides h2-k b –restricted ot-i (siinfekl) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
MBL International ot-i plus ot-ii peptides
Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with <t>PBS</t> (Control), with both OT-I and OT-II <t>specific</t> <t>peptides</t> plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.
Ot I Plus Ot Ii Peptides, supplied by MBL International, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ot-i plus ot-ii peptides/product/MBL International
Average 90 stars, based on 1 article reviews
ot-i plus ot-ii peptides - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Jackson Laboratory ot-i cd8 t cell transgenic mice recognizing amino acids 257–264 of ovalbumin
Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with <t>PBS</t> (Control), with both OT-I and OT-II <t>specific</t> <t>peptides</t> plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.
Ot I Cd8 T Cell Transgenic Mice Recognizing Amino Acids 257–264 Of Ovalbumin, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ot-i cd8 t cell transgenic mice recognizing amino acids 257–264 of ovalbumin/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
ot-i cd8 t cell transgenic mice recognizing amino acids 257–264 of ovalbumin - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Innovagen AB ot-i peptide siinfekl
Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with <t>PBS</t> (Control), with both OT-I and OT-II <t>specific</t> <t>peptides</t> plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.
Ot I Peptide Siinfekl, supplied by Innovagen AB, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ot-i peptide siinfekl/product/Innovagen AB
Average 90 stars, based on 1 article reviews
ot-i peptide siinfekl - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Jackson Laboratory ovalbumin peptide-specific ot-i and ot-ii transgenic t-cell ovalbumin
Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with <t>PBS</t> (Control), with both OT-I and OT-II <t>specific</t> <t>peptides</t> plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.
Ovalbumin Peptide Specific Ot I And Ot Ii Transgenic T Cell Ovalbumin, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ovalbumin peptide-specific ot-i and ot-ii transgenic t-cell ovalbumin/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
ovalbumin peptide-specific ot-i and ot-ii transgenic t-cell ovalbumin - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
AnaSpec ova peptide sinfekl
IEC of Rnf5 −/− mice activate immune response and change anti-microbial peptide (AMP) expression. a Villi length and crypt depth calculated from H&E-stained sections of intestines from WT or Rnf5 −/− mice (WT, n = 30; Rnf5 −/− , n = 32). b qRT-PCR analysis of AMPs mRNA levels in IECs from small intestine of naive WT or Rnf5 −/− mice ( n = 6). c Representative images (left) and quantification (right) of cleaved caspase-3 immunostained small intestine organoids from tumor-bearing WT or Rnf5 −/− mice ( n = 3). Scale bar = 100μm. Graph shows percentage of cleaved caspase-3 + cells per immunostained organoid ( n = 12 fields). d Intracellular IFN-γ and TNF-α staining of p14 CD8 + T cells incubated for 72 h with 2 μg/ml GP33 peptide recognized by the TCR of P14 and bone marrow-derived dendritic cells (BMDCs) that were incubated with medium alone (no stimulation) or with conditioned medium (CM) from shControl or shRNF5 MODE-K cells. e Representative images (left) and quantification (right) of CD11c + cell immunostaining in the small intestine of WT or Rnf5 −/− mice on day 24 after injection of YUMM1.5 cells. Scale bar = 50μm ( n = 4). f Frequencies of total DCs and pDCs in Peyer’s patches from WT and Rnf5 −/− mice on day 10 after YUMM1.5 cell injection ( n = 6). g 10 days after tumor injection, DCs from GALT, dLN, and ndLN were isolated, pooled per group ( n = 10 mice/group), and were incubated with OT-1 CD8 + T cells stimulated with 2 μg/ml <t>OVA</t> peptide <t>(SINFEKL).</t> Intracellular IFN-γ and TNF-α of OT-1 CD8 + T cells were detected. Data are representative of three independent experiments ( b , d ) and two independent experiments ( a , c , e , f , g ) ≥3 mice per group. Graphs show the mean ± s.e.m. * P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001 by two-tailed t test or Mann–Whitney U test ( a , b , c , e , f ) or one-way ANOVA with Tukey’s ( d ) correction for multiple comparisons
Ova Peptide Sinfekl, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ova peptide sinfekl/product/AnaSpec
Average 90 stars, based on 1 article reviews
ova peptide sinfekl - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Genemed Synthesis h2-k b –restricted ot-i and ot-ii peptides
IEC of Rnf5 −/− mice activate immune response and change anti-microbial peptide (AMP) expression. a Villi length and crypt depth calculated from H&E-stained sections of intestines from WT or Rnf5 −/− mice (WT, n = 30; Rnf5 −/− , n = 32). b qRT-PCR analysis of AMPs mRNA levels in IECs from small intestine of naive WT or Rnf5 −/− mice ( n = 6). c Representative images (left) and quantification (right) of cleaved caspase-3 immunostained small intestine organoids from tumor-bearing WT or Rnf5 −/− mice ( n = 3). Scale bar = 100μm. Graph shows percentage of cleaved caspase-3 + cells per immunostained organoid ( n = 12 fields). d Intracellular IFN-γ and TNF-α staining of p14 CD8 + T cells incubated for 72 h with 2 μg/ml GP33 peptide recognized by the TCR of P14 and bone marrow-derived dendritic cells (BMDCs) that were incubated with medium alone (no stimulation) or with conditioned medium (CM) from shControl or shRNF5 MODE-K cells. e Representative images (left) and quantification (right) of CD11c + cell immunostaining in the small intestine of WT or Rnf5 −/− mice on day 24 after injection of YUMM1.5 cells. Scale bar = 50μm ( n = 4). f Frequencies of total DCs and pDCs in Peyer’s patches from WT and Rnf5 −/− mice on day 10 after YUMM1.5 cell injection ( n = 6). g 10 days after tumor injection, DCs from GALT, dLN, and ndLN were isolated, pooled per group ( n = 10 mice/group), and were incubated with OT-1 CD8 + T cells stimulated with 2 μg/ml <t>OVA</t> peptide <t>(SINFEKL).</t> Intracellular IFN-γ and TNF-α of OT-1 CD8 + T cells were detected. Data are representative of three independent experiments ( b , d ) and two independent experiments ( a , c , e , f , g ) ≥3 mice per group. Graphs show the mean ± s.e.m. * P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001 by two-tailed t test or Mann–Whitney U test ( a , b , c , e , f ) or one-way ANOVA with Tukey’s ( d ) correction for multiple comparisons
H2 K B –Restricted Ot I And Ot Ii Peptides, supplied by Genemed Synthesis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/h2-k b –restricted ot-i and ot-ii peptides/product/Genemed Synthesis
Average 90 stars, based on 1 article reviews
h2-k b –restricted ot-i and ot-ii peptides - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with PBS (Control), with both OT-I and OT-II specific peptides plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.

Journal: eLife

Article Title: IL-2/JES6-1 mAb complexes dramatically increase sensitivity to LPS through IFN-γ production by CD25 + Foxp3 - T cells

doi: 10.7554/eLife.62432

Figure Lengend Snippet: Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with PBS (Control), with both OT-I and OT-II specific peptides plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.

Article Snippet: C57BL/6 mice were injected i.p. with PBS, OT-I plus OT-II peptides (10 and 50 μg/mouse, respectively; MBL International, Woburn, Massachusetts, USA; or Genscript, Piscataway, New Jersey, USA, respectively) plus polyI:C (75 μg/mouse; Sigma-Aldrich, St. Louis, Missouri, USA) or with the latter plus αIFN-γ mAb (250 μg/mouse; XMG1.2; BioXcell, Lebanon, New Hampshire, USA).

Techniques: Purification, Injection, Control, Flow Cytometry, Two Tailed Test

Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with PBS (Control), with both OT-I and OT-II specific peptides plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.

Journal: eLife

Article Title: IL-2/JES6-1 mAb complexes dramatically increase sensitivity to LPS through IFN-γ production by CD25 + Foxp3 - T cells

doi: 10.7554/eLife.62432

Figure Lengend Snippet: Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with PBS (Control), with both OT-I and OT-II specific peptides plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.

Article Snippet: C57BL/6 mice were injected i.p. with PBS, OT-I plus OT-II peptides (10 and 50 μg/mouse, respectively; MBL International, Woburn, Massachusetts, USA; or Genscript, Piscataway, New Jersey, USA, respectively) plus polyI:C (75 μg/mouse; Sigma-Aldrich, St. Louis, Missouri, USA) or with the latter plus αIFN-γ mAb (250 μg/mouse; XMG1.2; BioXcell, Lebanon, New Hampshire, USA).

Techniques: Purification, Injection, Control, Flow Cytometry, Two Tailed Test

IEC of Rnf5 −/− mice activate immune response and change anti-microbial peptide (AMP) expression. a Villi length and crypt depth calculated from H&E-stained sections of intestines from WT or Rnf5 −/− mice (WT, n = 30; Rnf5 −/− , n = 32). b qRT-PCR analysis of AMPs mRNA levels in IECs from small intestine of naive WT or Rnf5 −/− mice ( n = 6). c Representative images (left) and quantification (right) of cleaved caspase-3 immunostained small intestine organoids from tumor-bearing WT or Rnf5 −/− mice ( n = 3). Scale bar = 100μm. Graph shows percentage of cleaved caspase-3 + cells per immunostained organoid ( n = 12 fields). d Intracellular IFN-γ and TNF-α staining of p14 CD8 + T cells incubated for 72 h with 2 μg/ml GP33 peptide recognized by the TCR of P14 and bone marrow-derived dendritic cells (BMDCs) that were incubated with medium alone (no stimulation) or with conditioned medium (CM) from shControl or shRNF5 MODE-K cells. e Representative images (left) and quantification (right) of CD11c + cell immunostaining in the small intestine of WT or Rnf5 −/− mice on day 24 after injection of YUMM1.5 cells. Scale bar = 50μm ( n = 4). f Frequencies of total DCs and pDCs in Peyer’s patches from WT and Rnf5 −/− mice on day 10 after YUMM1.5 cell injection ( n = 6). g 10 days after tumor injection, DCs from GALT, dLN, and ndLN were isolated, pooled per group ( n = 10 mice/group), and were incubated with OT-1 CD8 + T cells stimulated with 2 μg/ml OVA peptide (SINFEKL). Intracellular IFN-γ and TNF-α of OT-1 CD8 + T cells were detected. Data are representative of three independent experiments ( b , d ) and two independent experiments ( a , c , e , f , g ) ≥3 mice per group. Graphs show the mean ± s.e.m. * P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001 by two-tailed t test or Mann–Whitney U test ( a , b , c , e , f ) or one-way ANOVA with Tukey’s ( d ) correction for multiple comparisons

Journal: Nature Communications

Article Title: Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 −/ − mice

doi: 10.1038/s41467-019-09525-y

Figure Lengend Snippet: IEC of Rnf5 −/− mice activate immune response and change anti-microbial peptide (AMP) expression. a Villi length and crypt depth calculated from H&E-stained sections of intestines from WT or Rnf5 −/− mice (WT, n = 30; Rnf5 −/− , n = 32). b qRT-PCR analysis of AMPs mRNA levels in IECs from small intestine of naive WT or Rnf5 −/− mice ( n = 6). c Representative images (left) and quantification (right) of cleaved caspase-3 immunostained small intestine organoids from tumor-bearing WT or Rnf5 −/− mice ( n = 3). Scale bar = 100μm. Graph shows percentage of cleaved caspase-3 + cells per immunostained organoid ( n = 12 fields). d Intracellular IFN-γ and TNF-α staining of p14 CD8 + T cells incubated for 72 h with 2 μg/ml GP33 peptide recognized by the TCR of P14 and bone marrow-derived dendritic cells (BMDCs) that were incubated with medium alone (no stimulation) or with conditioned medium (CM) from shControl or shRNF5 MODE-K cells. e Representative images (left) and quantification (right) of CD11c + cell immunostaining in the small intestine of WT or Rnf5 −/− mice on day 24 after injection of YUMM1.5 cells. Scale bar = 50μm ( n = 4). f Frequencies of total DCs and pDCs in Peyer’s patches from WT and Rnf5 −/− mice on day 10 after YUMM1.5 cell injection ( n = 6). g 10 days after tumor injection, DCs from GALT, dLN, and ndLN were isolated, pooled per group ( n = 10 mice/group), and were incubated with OT-1 CD8 + T cells stimulated with 2 μg/ml OVA peptide (SINFEKL). Intracellular IFN-γ and TNF-α of OT-1 CD8 + T cells were detected. Data are representative of three independent experiments ( b , d ) and two independent experiments ( a , c , e , f , g ) ≥3 mice per group. Graphs show the mean ± s.e.m. * P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001 by two-tailed t test or Mann–Whitney U test ( a , b , c , e , f ) or one-way ANOVA with Tukey’s ( d ) correction for multiple comparisons

Article Snippet: Cells were then mixed 1:1 with the BMDCs and incubated for 72 h pulsed with 2 μg/ml of OVA peptide (SINFEKL) (AnaSpec) or GP33 peptide (AnaSpec).

Techniques: Expressing, Staining, Quantitative RT-PCR, Incubation, Derivative Assay, Immunostaining, Injection, Isolation, Two Tailed Test, MANN-WHITNEY